How Does Fusidic Acid Work in the Body
Chemical Composition, Mechanism of Action & Metabolic Effects Explained
Table of Contents
- Key Takeaways
- Chemical Composition & Molecular Structure of Fusidic Acid
- Mechanism of Action: How Fusidic Acid Kills Bacteria
- Protein Synthesis Inhibition: Fusidic Acid's Core Mechanism
- Absorption & Distribution of Fusidic Acid in Skin
- Metabolic Effects and Elimination of Fusidic Acid
- Clinical Efficacy of Fusidic Acid for Skin Infections
- Fusidic Acid Mechanism FAQs
Key Takeaways: How Fusidic Acid Works
- Primary Action: Inhibits bacterial protein synthesis by targeting elongation factor G (EF-G)
- Chemical Class: Steroid-like antibiotic derived from Fusidium coccineum fungus
- Bacterial Spectrum: Highly active against Gram-positive bacteria, especially Staphylococcus aureus
- Effect on Bacteria: Bacteriostatic (stops growth) at therapeutic concentrations
- Skin Penetration: Excellent penetration into skin layers with minimal systemic absorption
- Common Uses: Impetigo, folliculitis, infected eczema, and other superficial skin infections
Fusidic acid works by specifically blocking protein production in bacteria, stopping them from multiplying and allowing your immune system to clear the infection. This targeted action makes it highly effective for common skin infections like impetigo and folliculitis without harming your own cells.
Important Medical Advice
If you experience a severe allergic reaction (rash, difficulty breathing, swelling of face/mouth/lips) or develop an eye infection after accidental contact, seek immediate medical attention. Avoid applying near eyes or on large areas of broken skin without medical supervision.
Chemical Composition & Molecular Structure of Fusidic Acid
Fusidic acid is a unique antibiotic with a steroid-like structure, isolated from the fungus Fusidium coccineum. Its chemical properties enable selective bacterial inhibition.
Chemical Structure Details
3α,11α,16β-trihydroxy-29-nor-8α,9β,13α,14β-dammara-17(20),24-dien-21-oic acid 16-acetate
This complex terpenoid structure resembles steroids but has distinct antibacterial properties.
C31H48O6
31 carbon, 48 hydrogen, and 6 oxygen atoms forming the backbone.
516.7 g/mol
This relatively large molecule contributes to its low systemic absorption when applied topically.
Key Pharmaceutical Properties
| Property | Value/Characteristic | Clinical Significance |
|---|---|---|
| Solubility | Poorly water-soluble, formulated in cream with paraffins | Ensures good retention in skin layers |
| pKa | 5.35 (weak acid) | Predominantly non-ionized at skin pH, enhancing penetration |
| Protein Binding | 97-99% bound to plasma proteins (if absorbed) | Minimizes systemic effects after topical use |
| Log P (octanol-water) | 4.8 (lipophilic) | Readily partitions into bacterial membranes |
🗒️ Pharmaceutical Insight: The steroid-like skeleton of fusidic acid allows it to mimic bacterial elongation factor binding sites, but it has no corticosteroid activity. This unique structure explains why resistance develops through distinct mechanisms.
Mechanism of Action: How Fusidic Acid Kills Bacteria
Fusidic acid works by interfering with bacterial protein synthesis at the ribosome level. It specifically targets Gram-positive bacteria, particularly staphylococci.
Step-by-Step Antibacterial Action
- Entry into Bacteria: Fusidic acid diffuses through the bacterial cell wall (aided by its lipophilic nature) and accumulates in the cytoplasm.
- Target Binding: It binds to elongation factor G (EF-G) when EF-G is complexed with the ribosome and GDP.
- Stabilization of Complex: The drug stabilizes the EF-G/GDP/ribosome complex, preventing EF-G from releasing after translocation.
- Translocation Blocked: With EF-G trapped, the ribosome cannot move along mRNA, and protein synthesis halts.
- Bacteriostatic Effect: Bacteria cannot produce essential proteins; growth stops, and the immune system clears the infection.
Visual Representation of Inhibition
| Normal Protein Synthesis | With Fusidic Acid |
|---|---|
| EF-G binds ribosome, hydrolyses GTP, promotes translocation, then detaches | EF-G binds ribosome but cannot detach after GTP hydrolysis |
| Ribosome moves to next codon, new amino acids added | Ribosome is frozen on mRNA, no further elongation |
| Bacteria multiply rapidly | Bacteria stop dividing, become susceptible to immune defence |
🗒️ Microbiological Insight: Fusidic acid is highly selective for bacterial EF-G; human mitochondrial EF-G is structurally different, explaining why the drug doesn't inhibit our own protein synthesis at therapeutic concentrations.
Protein Synthesis Inhibition: Fusidic Acid's Core Mechanism
At the molecular level, fusidic acid's interference with elongation factor G (EF-G) is a precise and well-understood process.
Key Molecular Interactions
Domain III of EF-G
Fusidic acid binds to a pocket on EF-G that becomes exposed when EF-G is ribosome-bound.
Kd ~ 10 nM
Very high affinity, ensuring potent inhibition at low concentrations.
Locks EF-G in GDP-bound form
Prevents the conformational shift needed for EF-G release.
Consequences for Bacteria
- Rapid cessation of protein synthesis: Within minutes of drug exposure, incorporation of amino acids stops.
- Accumulation of incomplete peptides: Some truncated proteins may be produced, but they are non-functional.
- Bacterial stasis: Bacteria enter a dormant state, unable to replicate or produce toxins.
- Immune clearance: Host defences (neutrophils, macrophages) eliminate the static bacteria.
🗒️ Research Note: Fusidic acid is one of the few antibiotics that target EF-G, making it valuable against resistant strains that evade other drug classes.
Absorption & Distribution of Fusidic Acid in Skin
When applied topically as a cream, fusidic acid's pharmacokinetics are designed to maximize local effect while minimizing systemic exposure.
Topical Pharmacokinetics
| Parameter | Value | Clinical Implication |
|---|---|---|
| Penetration into stratum corneum | Rapid within 30 minutes | Quick onset of action against surface bacteria |
| Concentration in deeper epidermis | Therapeutic levels maintained for 6-8 hours | Supports twice-daily or thrice-daily dosing |
| Systemic absorption | < 0.5% of applied dose | Negligible risk of systemic side effects |
| Accumulation with repeated use | Minimal due to low absorption | Safe for up to 2 weeks of continuous use |
Factors Affecting Skin Penetration
- Skin integrity: Broken or inflamed skin may allow slightly higher absorption – use only as directed.
- Occlusion: Covering with a dressing can increase local concentration (sometimes used for resistant infections under medical advice).
- Site of application: Face and flexural areas may absorb slightly more; avoid eye area.
🗒️ Clinical Tip: For maximum efficacy, apply fusidic acid cream to clean, dry skin and rub in gently. Avoid washing the area for at least 30 minutes to allow absorption.
Metabolic Effects and Elimination of Fusidic Acid
Although systemic absorption is minimal after topical use, understanding metabolism helps predict safety and interactions if higher exposure occurs (e.g., with extensive use on damaged skin).
Metabolic Pathway (if absorbed)
Hepatic Metabolism
Enzymes: CYP3A4 (major), other CYP isoforms
Process: Oxidation and conjugation
Metabolites: Several less active or inactive products
Elimination
Primary route: Biliary excretion (98% in faeces)
Renal: Minimal (<1% unchanged in urine)
Half-life (systemic): 5-6 hours after oral dose
Implications for Topical Use
- No dosage adjustment needed for renal or hepatic impairment when used topically.
- Drug interactions via CYP3A4 are clinically insignificant with topical application.
- Prolonged use over large areas (e.g., >10% body surface) could theoretically lead to detectable systemic levels – avoid without medical supervision.
🗒️ Safety Note: Based on the PIL, fusidic acid cream can be used during pregnancy and breastfeeding because systemic exposure is negligible. However, avoid applying directly to the breast while nursing.
Clinical Efficacy of Fusidic Acid for Skin Infections
Fusidic acid is a first-line topical antibiotic for common bacterial skin infections, with well-documented efficacy.
Indications and Success Rates
| Condition | Typical Pathogen | Clinical Cure Rate |
|---|---|---|
| Impetigo (non-bullous) | S. aureus, S. pyogenes | 85-95% after 5-7 days |
| Folliculitis | S. aureus | 80-90% with 7-10 day course |
| Infected eczema/dermatitis | S. aureus | Improvement in 70-80% (often combined with steroid) |
| Paronychia (acute) | S. aureus, anaerobes | Good response if caught early |
Optimal Use Guidelines
- Frequency: Apply 3-4 times daily, or as prescribed.
- Duration: Usually 1-2 weeks; complete the course even if symptoms improve.
- Hygiene: Wash hands before and after application to prevent spread.
- Monitoring: If no improvement in 7 days, reassess by a doctor.
- Avoid: Contact with eyes, mucous membranes, and large areas of broken skin.
🗒️ GP Insight: Fusidic acid resistance in S. aureus is increasing in some regions due to overuse. Always use exactly as prescribed and avoid sharing creams.
Fusidic Acid Mechanism FAQs
How does fusidic acid kill bacteria without harming human cells?
Fusidic acid specifically targets bacterial elongation factor G (EF-G), which has a different structure from human mitochondrial EF-G. It does not bind to human ribosomes, so our protein synthesis remains unaffected.
How long does fusidic acid take to start working on skin infections?
Fusidic acid begins inhibiting bacterial protein synthesis within minutes of application. Visible improvement in redness and crusting usually occurs within 2-3 days of regular use.
Can fusidic acid be absorbed into the bloodstream?
When applied topically as directed, absorption through intact skin is minimal (<0.5%). However, application to large areas of broken skin or under occlusive dressings may increase absorption slightly.
What bacteria does fusidic acid work against?
It is highly active against Gram-positive bacteria, particularly Staphylococcus aureus and Streptococcus species. It also works against Corynebacterium minutissimum (erythrasma) and some anaerobes.
Why should fusidic acid not be used for long periods?
Prolonged use (beyond 2 weeks) increases the risk of bacterial resistance developing and may cause skin sensitisation or irritation. Always follow your doctor's prescribed duration.
Need Treatment for a Skin Infection?
If you have symptoms of impetigo, folliculitis, or other bacterial skin infection, speak with a UK-registered doctor through a confidential online consultation.
Secure Prescription & Next-Day Delivery
MHRA-compliant | GPhC-registered pharmacy | Discreet packaging | UK-registered doctors
Start Skin Infection ConsultationRelated Fusidic Acid Guides
Medical Content Manager
Nabeel is a co-founder, and medical content manager of Chemist Doctor. He works closely with our medical team to ensure the information is accurate and up-to-date.
Medical Doctor
Dr. Feroz is a GMC-registered doctor and a medical reviewer at Chemist Doctor. He oversees acute condition and urgent care guidance.
Medical Director
Usman is a co-founder, and medical director of Chemist Doctor. He leads the organisation's strategic vision, bridging clinical and operational priorities.
Review Date: 21 February 2026
Next Review: 21 August 2026
Published on: 21 February 2026
Last Updated: 21 February 2026